Skip to content
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
get in touch
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
get in touch

Press Releases

Press Releases

  • 2017, Press Releases

    X‑Chem and Vertex Enter into Multi-Target Genetic Disease Collaboration

    Download PDF – Agreement will enable discovery of small-molecule [...]

  • 2017, Press Releases

    X‑Chem Announces Publication in Nature

    Download PDF – Crystal Structure of PAR2 complexed with [...]

  • 2017, Press Releases

    X‑Chem and Ono Enter into Multi-Target Drug Discovery Collaboration

    Download PDF – Agreement marks X-Chem’s third drug discovery [...]

  • 2017, Press Releases

    X‑Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas

    Download PDF WALTHAM, Mass. – March 20 2017 [...]

  • 2017, Press Releases

    X‑Chem Expands Collaboration with Janssen in Inflammatory Diseases

    Download PDF — Event represents X-Chem’s fifth collaboration expansion [...]

  • 2016, Press Releases

    X‑Chem Marks the Spot for Bayer in Sweetened Drug Discovery Deal

    July 13 2016 | BIOWORLD TODAY | Bayer AG and [...]

Previous56
Back to Resource Center
North America
Europe

United States

X-Chem Global HQ
100 Beaver Street
Waltham, MA 02453
United States
Map

Canada

X-Chem Canada
4800 Rue Levy
Montreal, QC H4R 2P1
Canada
Map

Hungary

X-Chem Europe
Graphisoft Park (Building D)
1031 Budapest, Záhony u. 7.
Hungary
Map

Terms & Conditions

© 2025 X-Chem, Inc. • All Rights Reserved

Sign-up for Our Newsletter

Be first to see what’s next in drug discovery.

X-Chem may contact you with relevant updates. Unsubscribe anytime. See our Privacy Policy.

Terms & Conditions

© 2025 X-Chem, Inc. • All Rights Reserved

Page load link
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
P : +1 781.419.6900
Email Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Go to Top